Stilboestrol and vaginal clear-cell adenocarcinoma syndrome.

BMJ 1978; 1 doi: 10.1136/bmj.1.6127.1588 (Published 17 June 1978)
Cite this as: BMJ 1978;1:1588
  1. J M Monaghan,
  2. L A Sirisena

    Abstract

    A vaginal clear-cell adenocarcinoma developed in a young woman who had been exposed in utero to maternal stilboestrol treatment. During 1940-71 in the UK some 7500 women were given stilboestrol during pregnancy. Thus more cases are likely to appear and clinicians caring for young women should be alert to this possibility.

    THIS WEEK'S POLL